PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,000 | +50.0% | 2,855 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -87.2% | 2,855 | -77.8% | 0.00% | -100.0% |
| Q4 2019 | $47,000 | -41.2% | 12,884 | -45.0% | 0.00% | -40.0% |
| Q3 2019 | $80,000 | +300.0% | 23,413 | +450.6% | 0.01% | +400.0% |
| Q2 2019 | $20,000 | +300.0% | 4,252 | +161.8% | 0.00% | – |
| Q1 2019 | $5,000 | -68.8% | 1,624 | -73.1% | 0.00% | -100.0% |
| Q4 2018 | $16,000 | -68.0% | 6,047 | -31.2% | 0.00% | -75.0% |
| Q3 2018 | $50,000 | -99.9% | 8,788 | -5.0% | 0.00% | 0.0% |
| Q2 2018 | $46,888,000 | +426154.5% | 9,248 | +447.2% | 0.00% | +300.0% |
| Q1 2018 | $11,000 | +83.3% | 1,690 | +92.9% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | – | 876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |